Increasing Endocannabinoid Levels in the Ventral Pallidum Restore Aberrant Dopamine Neuron Activity in the Subchronic PCP Rodent Model of Schizophrenia

BACKGROUND: Schizophrenia is a debilitating disorder that affects 1% of the US population. While the exogenous administration of cannabinoids such as tetrahydrocannabinol is reported to exacerbate psychosis in schizophrenia patients, augmenting the levels of endogenous cannabinoids has gained attent...

Descripción completa

Detalles Bibliográficos
Autores principales: Aguilar, David D, Chen, Li, Lodge, Daniel J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332795/
https://www.ncbi.nlm.nih.gov/pubmed/25539511
http://dx.doi.org/10.1093/ijnp/pyu035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332795/
https://www.ncbi.nlm.nih.gov/pubmed/25539511
http://dx.doi.org/10.1093/ijnp/pyu035

Ejemplares similares